165 related articles for article (PubMed ID: 22626793)
1. What improves minimal hepatic encephalopathy: probiotic yogurt, protein restriction or nonabsorbable disaccharides?
Alfawaz HA; Aljumah AA
Saudi J Gastroenterol; 2012; 18(3):153-4. PubMed ID: 22626793
[No Abstract] [Full Text] [Related]
2. Lactulose for minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction.
Sharma P; Sharma BC
Saudi J Gastroenterol; 2012; 18(3):168-72. PubMed ID: 22626795
[TBL] [Abstract][Full Text] [Related]
3. A pilot study using lactulose in management of minimal hepatic encephalopathy in children with extrahepatic portal vein obstruction.
El-Karaksy HM; Afifi O; Bakry A; Kader AA; Saber N
World J Pediatr; 2017 Feb; 13(1):70-75. PubMed ID: 27878780
[TBL] [Abstract][Full Text] [Related]
4. Disaccharides in the treatment of hepatic encephalopathy.
Sharma P; Sharma BC
Metab Brain Dis; 2013 Jun; 28(2):313-20. PubMed ID: 23456517
[TBL] [Abstract][Full Text] [Related]
5. Lactulose Management of Minimal Hepatic Encephalopathy: A Systematic Review.
Zucker DM; Redulla R
Gastroenterol Nurs; 2019; 42(1):84-94. PubMed ID: 30688711
[TBL] [Abstract][Full Text] [Related]
6. Current state of knowledge of hepatic encephalopathy (part III): non-absorbable disaccharides.
Morgan MY
Metab Brain Dis; 2016 Dec; 31(6):1361-1364. PubMed ID: 27638474
[TBL] [Abstract][Full Text] [Related]
7. Nonabsorbable disaccharides for hepatic encephalopathy.
Als-Nielsen B; Gluud LL; Gluud C
Cochrane Database Syst Rev; 2004; (2):CD003044. PubMed ID: 15106187
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic Management of Hepatic Encephalopathy.
Khalessi A; Pyrsopoulos NT
Clin Liver Dis; 2024 May; 28(2):287-296. PubMed ID: 38548440
[TBL] [Abstract][Full Text] [Related]
9. [Old wine in new bottles: Lactulose works in hepatic encephalopathy].
Bendtsen F
Ugeskr Laeger; 2016 Oct; 178(42):. PubMed ID: 27745574
[No Abstract] [Full Text] [Related]
10. Beyond Lactulose: Treatment Options for Hepatic Encephalopathy.
Gastroenterol Nurs; 2019; 42(3):E3-E4. PubMed ID: 31145254
[No Abstract] [Full Text] [Related]
11. Treatment of hepatic encephalopathy: it's not lactulose.
Shawcross DL; Jalan R
BMJ; 2004 Jul; 329(7457):112; author reply 112. PubMed ID: 15242927
[No Abstract] [Full Text] [Related]
12. Lactulose vs Polyethylene Glycol for Treatment of Hepatic Encephalopathy.
Tapper EB
JAMA Intern Med; 2015 May; 175(5):868. PubMed ID: 25938321
[No Abstract] [Full Text] [Related]
13. Lactulose vs Polyethylene Glycol for Treatment of Hepatic Encephalopathy.
Cutler T; Mints G
JAMA Intern Med; 2015 May; 175(5):867-8. PubMed ID: 25938320
[No Abstract] [Full Text] [Related]
14. Can we ignore minimal hepatic encephalopathy any longer?
Qadri AM; Ogunwale BO; Mullen KD
Hepatology; 2007 Mar; 45(3):547-8. PubMed ID: 17326151
[No Abstract] [Full Text] [Related]
15. Lactulose treatment for hepatic encephalopathy, gastrointestinal symptoms, and health-related quality of life.
Kalaitzakis E; Björnsson E
Hepatology; 2007 Sep; 46(3):949-50; author reply 951. PubMed ID: 17879365
[No Abstract] [Full Text] [Related]
16. Lactulose vs Polyethylene Glycol for Treatment of Hepatic Encephalopathy-Reply.
Rahimi RS; Cuthbert JA; Rockey DC
JAMA Intern Med; 2015 May; 175(5):868-9. PubMed ID: 25938322
[No Abstract] [Full Text] [Related]
17. ACP Journal Club. Adding rifaximin to lactulose increased reversal and decreased mortality in hepatic encephalopathy.
Kowdley KV; Burman BE
Ann Intern Med; 2013 Oct; 159(8):JC8. PubMed ID: 24126669
[No Abstract] [Full Text] [Related]
18. Predictors of nonresponse to lactulose in patients with cirrhosis and hepatic encephalopathy.
Sharma P; Sharma BC; Sarin SK
Eur J Gastroenterol Hepatol; 2010 May; 22(5):526-31. PubMed ID: 20009938
[TBL] [Abstract][Full Text] [Related]
19. How to dispel myths in the treatment of hepatic encephalopathy?
Braillon A
Nat Clin Pract Gastroenterol Hepatol; 2007 Oct; 4(10):E1; author reply E2. PubMed ID: 17909528
[No Abstract] [Full Text] [Related]
20. Should We Treat Minimal/Covert Hepatic Encephalopathy, and with What?
Henderson PK; Herrera JL
Clin Liver Dis; 2015 Aug; 19(3):487-95. PubMed ID: 26195203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]